View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
EUR 239.43
GRF GRIFOLS S.A.

Grifols S.A.: New issuer: one of the largest producers of human blood ...

Our credit view of this issuer reflects its good product safety track record, against its sanitary risk.

10h / 26m 10h / 26m 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A.: FAQ: Still fragile liquidity and slow return to cash gen...

Grifols' recent actions will address looming bond maturities in the first half of 2025, but the global healthcare company still faces large debt maturities in 2027.

06/10/24 June 10, 2024 1 EN
EUR 239.43
GRF GRIFOLS S.A.

Grifols S.A.: Update following ratings placed on review for downgrade

Our credit view of Grifols reflects its good market position, combined with an aggressive financial policy, elevated leverage and weak governance practices.

04/25/24 April 25, 2024 1 EN
EUR 172.39
GRF GRIFOLS S.A.

Moody's Ratings says Grifols' ratings remain unaffected by new senior ...

Moody's Ratings (Moody's) has informed today that Grifols S.A.'s (Grifols, B2 ratings under review) ratings remain unaffected by the signing of a private offering of €1.0 billion senior secured notes due 2030 which proceeds will be used to repay its existing €1.0 billion senior unsecured notes due M...

04/24/24 April 24, 2024 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - December 2023 (LTM): Peer Snapshot 

Compares key performance metrics against industry peers.

03/25/24 March 25, 2024 1 EN
EUR 172.39
GRF GRIFOLS S.A.

Moody's says Grifols' asset disposal and planned debt reduction are cr...

Moody's Investors Service (Moody's) informed today that Grifols S.A.'s (Grifols, B2 negative) disposal of a stake in Shanghai RAAS (SRAAS) and its commitment to use related proceeds to reduce its gross debt are credit positive. However, there is no immediate impact on the ratings and outlook of Grif...

01/04/24 January 4, 2024 1 EN
EUR 191.54
GRF GRIFOLS S.A.

Grifols S.A.: Key facts and statistics - LTM June 2023

A summary company profile, detailing Grifols’ business operations and financial highlights.

10/08/23 October 8, 2023 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - June 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

09/14/23 September 14, 2023 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - December 2022 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

03/31/23 March 31, 2023 1 EN
EUR 239.43
GRF GRIFOLS S.A.

Grifols S.A.: Update following downgrade to B2; outlook negative

Our credit view of Grifols reflects its leading market position in the plasma derivatives sector, against its high leverage and slow recovery from the effects of the pandemic.

03/24/23 March 24, 2023 1 EN
EUR 191.54
GRF GRIFOLS S.A.

Grifols S.A.: Cost efficiencies will boost profitability but leverage ...

Grifols' optimization plan will save €400 million of costs by 2024, but leverage will remain elevated.

02/20/23 February 20, 2023 1 EN
EUR 239.43
GRF GRIFOLS S.A.

Grifols S.A.: Update to credit analysis

Our credit view of Grifols reflects its leading market position in a sector with growing demand, mitigated by its high leverage and slow recovery from the effects of the pandemic.

09/22/22 September 22, 2022 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols Escrow Issuer, S.A.U.: Covenant Quality Post-Sale Snapshot: €1...

Grifols, S.A.’s covenant package provides lower-tier weak protection (4.05).

10/20/21 October 20, 2021 7 EN
EUR 239.43
GRF GRIFOLS S.A.

Grifols S.A.: Update following downgrade to B1

Our credit view of Grifols S.A. reflects its high leverage and recent debt-funded acquisitions, which will, nonetheless, further improve its solid position in the plasma industry.

09/28/21 September 28, 2021 11 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - June 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

08/30/21 August 30, 2021 1 EN
EUR 172.39
GRF GRIFOLS S.A.

Moody's says Grifols' ratings unchanged following lenders' consent on ...

Announcement: Moody's says Grifols' ratings unchanged following lenders' consent on certain debt terms' amendments. Global Credit Research- 17 Aug 2021. Paris, August 17, 2021-- Moody's Investors Service today said that Grifols S.A.' s Ba3 corporate family rating, Ba2 senior secured instrument ratings and B2 senior unsecured instrument rating remain unchanged following lenders' consent on certain amendments to existing debt instruments' terms.

08/17/21 August 17, 2021 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - March 2021 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

08/04/21 August 4, 2021 1 EN
EUR 191.54
GRF GRIFOLS S.A.

Grifols S.A.: Grifols’ transaction with GIC unlikely to improve Moody’...

GIC will invest $1 billion in Grifols' US subsidiary Biomat through newly issued non-voting stock.

07/16/21 July 16, 2021 4 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - December 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

03/31/21 March 31, 2021 1 EN
EUR 718.28
GRF GRIFOLS S.A.

Grifols S.A. - September 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

11/27/20 November 27, 2020 1 EN
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch